PET-CT combines positron emission tomography and computed tomography to enhance diagnostic accuracy by providing both functional and anatomical imaging. The procedure involves using radiopharmaceuticals to visualize metabolic activities in tissues, with a history dating back to the late 1950s and significant advancements in the 1990s. While offering benefits such as improved lesion localization and tumor staging, risks include exposure to radiation and the potential for claustrophobia.